Boehringer Ingelheim Adopts LifeSphere NavaX for Enhanced Pharmacovigilance

Boehringer Ingelheim Adopts LifeSphere NavaX for Enhanced Pharmacovigilance

Boehringer Ingelheim has implemented LifeSphere NavaX to improve its pharmacovigilance operations, achieving 90% data accuracy and increased efficiency, announced in a press release.

Boehringer Ingelheim has implemented LifeSphere NavaX, a solution by ArisGlobal, to enhance its pharmacovigilance operations, announced in a press release. This implementation is part of Boehringer's digital transformation strategy, utilizing GenAI and Dynamic Data Extraction technologies to process individual case safety reports with up to 90% data extraction accuracy.

The adoption of NavaX allows Boehringer Ingelheim to streamline case intake processes, significantly reducing manual efforts and accelerating timelines. This enables safety teams to focus on more critical tasks such as medical review and benefit-risk analysis. The successful deployment of NavaX marks a significant milestone in Boehringer's journey to modernize its safety operations through scalable, AI-powered automation.

ArisGlobal's NavaX is a cognitive computing engine that powers AI products across the LifeSphere Unify platform, offering advanced automation capabilities to meet growing regulatory demands and improve compliance. The implementation by Boehringer Ingelheim reflects a broader trend among top-tier pharmaceutical companies to modernize safety operations with AI-enabled automation.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Healthcare & Life Sciences AI
AI Brief (X)

More from: Healthcare & Life Sciences

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like